Amantadine amides prodrugs as hepatic delivery systems to enhance its activity against HCV

Digest Journal of Nanomaterials and Biostructures

Volumn 6, Issue 4, 2011, Pages 1675-1683

  Aboul Fadl, Tarek ^a,b   Sheha, Mahmoud M ^b   El Azab, Adel S ^b   Abdel Aziz, Hatem A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Assiut University   (Egypt)

Author keywords

Amantadine; Bile acids; HCV; Hepatic delivery system; Prodrug; Thiazolidine carboxylic acdis

Indexed keywords

HEPATITIS C VIRUS; MUS; RATTUS;

EID: 80755159445     PISSN: None     EISSN: 18423582     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. J. Y. Jang, R. T. Chung, Korean J Hepatol 16, 263(2010).
2. World Health Organization. Hepatitis C. Fact sheet number 164. Available from: URL: http://www.who.int/mediacentre/factsheets/fs164/en/
3. J.P. Smith, Dig Dis Sci 42, 1681(1997).
4. J.S. Golf, R.M. Reveille, A. Johnson, Dig Dis Sci 45, 1389(2000).
5. S. Brillanti, F. Levantesi, L. Masi, M. Foli, L. Bolondi, Hepatology 32, 630(2000).
6. D. Oguz, B. Cicek, L. Filik, B. Odemis, M. Kilic, E. Altintas, N. Zengin, E. Altiparmak. World J Gastroenterol 11, 580(2005).
7. C. G. Wermuth in"The Practice of Medicinal Chemistry", C. G. Wermuth (ed.), Academic Press, Amestrdam,(2003) pp569-679.
8. R. K. Verma and S. Garg, Pharm Tech. On-line 25, 1(2001).
9. O. B. Sutcliffe, R.C. Storr, T.L. Gilchrist, P. Rafferty. J. Chem. Soc., Perkin Trans. 1, 1795(2001).
10. A. Padwa, G.E. Fryxell, J.R. Gasdaska, M.K. Venkatramanan, G. S. K. Wong, J. Org. Chem. 54, 644 (1989).
11. D. Barbry, G. Ricart, D. Couturier. J. Chem. Soc., Perkin Trans. 2, 133(1990).
12. T. Aboul-Fadl, E. A. Fouad, Pharmazie 51, 30 (1996).
13. J. J. Pesek, J.H. Frost. Tetrahedron 31, 907(1975).